These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22095380)
21. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology. Ko EC; Jhala NC; Shultz JJ; Chhieng DC Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688 [TBL] [Abstract][Full Text] [Related]
22. Positive effusion cytology as the initial presentation of malignancy. Monte SA; Ehya H; Lang WR Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540 [TBL] [Abstract][Full Text] [Related]
23. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology. Ang PP; Tan GC; Karim N; Wong YP Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449 [TBL] [Abstract][Full Text] [Related]
25. Anaplastic large cell lymphoma diagnosed from ascitic and pleural fluid effusion cytology in a paediatric patient. Stephen N; Ravi S; Balakrishnan K; Siddaraju N; Basu D; Gochhait D; Ganesan P Cytopathology; 2020 Jul; 31(4):321-324. PubMed ID: 32369653 [No Abstract] [Full Text] [Related]
26. DNA Ploidy Analysis and Cell Block Immunohistochemistry in the Diagnosis of Malignant Effusions. Puri M; Sen R; Gupta M; Kalra R; Bhargava S; Puri K Acta Cytol; 2020; 64(3):256-264. PubMed ID: 31466063 [TBL] [Abstract][Full Text] [Related]
27. Role of computerized morphometric analysis in diagnosis of effusion specimens. Arora B; Setia S; Rekhi B Diagn Cytopathol; 2006 Oct; 34(10):670-5. PubMed ID: 16955473 [TBL] [Abstract][Full Text] [Related]
28. [Application of cell blocks to assist in precise cytological diagnosis of serous effusion]. Sun MJ; Liu LT; Li CY; Liu DG; Chen L Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):830-836. PubMed ID: 39103265 [No Abstract] [Full Text] [Related]
29. [Cytodiagnosis and cytomorphologic analysis of hematolymphoid malignancy in serous effusion: a study of 23 cases]. He SR; Peng WX; Sun MJ; Yang L; He L; Su XL; He Q; Liu DG Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):691-5. PubMed ID: 23302312 [TBL] [Abstract][Full Text] [Related]
30. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology. Oda T; Ogata S; Kawaguchi S; Minabe S; Dokyu M; Takahashi H; Kumazawa F; Shimazaki H; Takano M; Hase K; Ozeki Y; Kanoh S; Nakanishi K Diagn Cytopathol; 2016 Jun; 44(6):499-504. PubMed ID: 27015745 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Ong KC; Indumathi V; Poh WT; Ong YY Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675 [TBL] [Abstract][Full Text] [Related]
33. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology. Sahu S; Gupta P; Susheilia S; Gautam U; Dey P Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400 [TBL] [Abstract][Full Text] [Related]
34. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Garcia LW; Ducatman BS; Wang HH Mod Pathol; 1994 Aug; 7(6):665-8. PubMed ID: 7991525 [TBL] [Abstract][Full Text] [Related]
35. Comparison of pleural fluid cytology and pleural biopsy in the evaluation of pleural effusion. Kumar ND; Bhatia A; Misra K; Suri JC J Indian Med Assoc; 1995 Aug; 93(8):307-9. PubMed ID: 8713246 [TBL] [Abstract][Full Text] [Related]
36. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution. Lew M; Cantley R; Heider A; Jing X Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of pericardial fluid cytology: an analysis of 53 specimens from 44 consecutive patients. Malamou-Mitsi VD; Zioga AP; Agnantis NJ Diagn Cytopathol; 1996 Sep; 15(3):197-204. PubMed ID: 8955601 [TBL] [Abstract][Full Text] [Related]
39. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Illei PB; Ladanyi M; Rusch VW; Zakowski MF Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646 [TBL] [Abstract][Full Text] [Related]
40. Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Leichsenring J; Volckmar AL; Kirchner M; Kazdal D; Kriegsmann M; Stögbauer F; Bockmayr T; Klauschen F; Herth FJF; Penzel R; Warth A; Schirmacher P; Endris V; Stenzinger A Genes Chromosomes Cancer; 2018 Feb; 57(2):70-79. PubMed ID: 29044880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]